Target Price | $393.62 |
Price | $340.65 |
Potential | 15.55% |
Number of Estimates | 21 |
21 Analysts have issued a price target Sherwin-Williams 2026 . The average Sherwin-Williams target price is $393.62. This is 15.55% higher than the current stock price. The highest price target is $430.00 26.23% , the lowest is $300.00 11.93% . | |
A rating was issued by 30 analysts: 16 Analysts recommend Sherwin-Williams to buy, 11 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Sherwin-Williams stock has an average upside potential 2026 of 15.55% . Most analysts recommend the Sherwin-Williams stock at Purchase. |
23 Analysts have issued a sales forecast Sherwin-Williams 2025 . The average Sherwin-Williams sales estimate is $23.7b . This is 2.66% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $24.1b 4.26% , the lowest is $23.1b 0.05% .
This results in the following potential growth metrics:
2024 | $23.1b | 0.20% |
---|---|---|
2025 | $23.7b | 2.66% |
2026 | $25.0b | 5.23% |
2027 | $26.5b | 6.00% |
2028 | $27.2b | 2.93% |
24 Analysts have issued an Sherwin-Williams EBITDA forecast 2025. The average Sherwin-Williams EBITDA estimate is $4.8b . This is 7.96% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.0b 13.75% , the lowest is $4.6b 4.25% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $4.4b | 3.63% |
---|---|---|
2025 | $4.8b | 8.11% |
2026 | $5.2b | 9.57% |
2027 | $5.7b | 9.45% |
2028 | $5.7b | 0.10% |
2024 | 19.04% | 3.42% |
---|---|---|
2025 | 20.05% | 5.30% |
2026 | 20.88% | 4.14% |
2027 | 21.56% | 3.26% |
2028 | 20.97% | 2.74% |
11 Sherwin-Williams Analysts have issued a net profit forecast 2025. The average Sherwin-Williams net profit estimate is $2.9b . This is 8.43% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.1b 15.17% , the lowest is $2.7b 0.95% .
This results in the following potential growth metrics and future Net Margins:
2024 | $2.7b | 14.05% |
---|---|---|
2025 | $2.9b | 8.43% |
2026 | $3.3b | 13.39% |
2027 | $3.7b | 13.53% |
2028 | $3.8b | 2.94% |
2024 | 11.48% | 13.82% |
---|---|---|
2025 | 12.12% | 5.59% |
2026 | 13.06% | 7.76% |
2027 | 13.99% | 7.12% |
2028 | 13.99% | 0.00% |
11 Analysts have issued a Sherwin-Williams forecast for earnings per share. The average Sherwin-Williams EPS is $11.44 . This is 8.44% higher than earnings per share in the financial year 2024. The highest EPS forecast is $12.15 15.17% , the lowest is $10.65 0.95% .
This results in the following potential growth metrics and future valuations:
2024 | $10.55 | 14.05% |
---|---|---|
2025 | $11.44 | 8.44% |
2026 | $12.97 | 13.37% |
2027 | $14.73 | 13.57% |
2028 | $15.16 | 2.92% |
Current | 32.30 | 14.10% |
---|---|---|
2025 | 29.78 | 7.80% |
2026 | 26.26 | 11.82% |
2027 | 23.13 | 11.92% |
2028 | 22.47 | 2.85% |
Based on analysts' sales estimates for 2025, the Sherwin-Williams stock is valued at an EV/Sales of 4.15 and an P/S ratio of 3.61 .
This results in the following potential growth metrics and future valuations:
Current | 4.26 | 1.62% |
---|---|---|
2025 | 4.15 | 2.66% |
2026 | 3.94 | 4.97% |
2027 | 3.72 | 5.66% |
2028 | 3.61 | 2.85% |
Current | 3.71 | 3.12% |
---|---|---|
2025 | 3.61 | 2.60% |
2026 | 3.43 | 4.97% |
2027 | 3.24 | 5.66% |
2028 | 3.15 | 2.85% |
Sherwin-Williams...
Analyst | Rating | Action | Date |
---|---|---|---|
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 03 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 01 2025 |
Jefferies |
Buy
➜
Hold
|
Downgrade | Mar 10 2025 |
Citigroup |
➜
Buy
|
Unchanged | Feb 26 2025 |
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Feb 03 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Feb 03 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Jan 28 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Apr 03 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Apr 01 2025 |
Downgrade
Jefferies:
Buy
➜
Hold
|
Mar 10 2025 |
Unchanged
Citigroup:
➜
Buy
|
Feb 26 2025 |
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Feb 03 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Feb 03 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Jan 28 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.